Note 10. Earnings (Loss) per Share The following sets forth the calculation of earnings (loss) per share, or EPS, for the periods indicated (in thousands, except per share amounts): | | | | | | | | | For the Three Months Ended | | | March 31, | | | 2026 | | 2025 | Net income (loss) | | $ | (38,116) | | $ | (5,861) | Less: Net income allocated to participating securities | | | — | | | — | Basic and diluted earnings available to common stockholders | | $ | (38,116) | | $ | (5,861) | | | | | | | | Common shares: | | | | | | | Common shares outstanding — basic | | | 41,143 | | | 40,188 | Dilutive effect of potential common shares | | | — | | | — | Common shares outstanding — diluted | | | 41,143 | | | 40,188 | | | | | | | | Net earnings (loss) per share: | | | | | | | Basic | | $ | (0.93) | | $ | (0.15) | Diluted(1) | | $ | (0.93) | | $ | (0.15) |
| (1) | The Company excluded 423,257 and 248,775 restricted stock units from the diluted weighted-average common shares outstanding for the three months ended March 31, 2026 and 2025, respectively, because their effect was anti-dilutive. |
|